A vision of the pharmaceutical industry

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue SUPPL. A, 1998, Pages 5-9

  Munio S ^a  

^a Novartis Pharma SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

CONFERENCE PAPER; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; LAW; SPAIN;

DRUG INDUSTRY; DRUGS, GENERIC; FEES, PHARMACEUTICAL; HUMANS; LEGISLATION, DRUG; SPAIN; THERAPEUTIC EQUIVALENCY; UNITED STATES;

EID: 0031669865     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Law 13/1996 of 30 Dec,. Fiscal, Administrative and Social Order Measures. Article 169. Modification to Law 25/1990 of the Drugs Act.
2. Center for Drug Development, Tufts University. Boston.
3. Circular 3/97 del Ministerio de Sanidad y Consumo. Procedures tor Processing Applications for Generic Patent Medicines. Feb. 1997.
4. Pharma Market Scanner. Jan. 19, 1998, 146.
5. Bol Ter Andal 1997, 13(4).